IL17A and psoriasis: We have shown before that dermal over-expression of the cytokine IL-17A (K14-IL-17Aind/+) in mice results in severe psoriasis-like skin disease and simultaneous endothelial dysfunction, vascular inflammation, and arterial hypertension [11].